Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension

被引:0
|
作者
Karakurt, Zuhal [1 ]
机构
[1] Sureyyapasa Cogus Hastaliklari & Gogus Cerrahist, Gogus Hastaliklan Bolumu, Istanbul, Turkey
来源
关键词
Pulmonary veno-occlusive disease; pulmonary capillary hemangiomatosis; portopulmonary hypertension; HIV associated PAH; PORTOPULMONARY HYPERTENSION; LUNG-TRANSPLANTATION; SURVIVAL; SCLERODERMA; REGISTRY; THERAPY; PATIENT;
D O I
10.5152/akd.2010.121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic pulmonary arterial hypertension (PAH) is included in Group 1 of PAH classification, while pulmonary veno-occlusive disease (PVOD), pulmonary capillary hemangiomatosis (PCH), portopulmonary hypertension (PoPH) and HIV-associated PAH constitute the subgroups of Group I PAH disorders. PVOD has similar clinical presentation, hemodynamic characteristics and genetic background with PAH although main pathology is in venules and definite diagnosis is done by biopsy although not recommended due to high risk of bleeding. PCH, a rare idiopathic lung disorder, causes PAR in young adults and mostly is diagnosed after death by autopsy. PoPH is defined as PAR due to primary chronic liver disease associated with intrapulmonary vascular dilatations and hypoxia. HIV associated PAR is a rare complication of HIV-infection, and it is seen especially in HIV-infected patients with intravenous drug abuse. (Anadolu Kardiyol Derg 2010; 10: Suppl 1; 63-8)
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [41] Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis
    Reinero, Carol R.
    Jutkowitz, L. Ari
    Nelson, Nathan
    Masseau, Isabelle
    Jennings, Samuel
    Williams, Kurt
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2019, 33 (01) : 114 - 123
  • [42] Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension
    Lai, Ying-Ju
    Chen, Po-Ru
    Huang, Yen-Lin
    Hsu, Hsao-Hsun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 300 - 309
  • [43] Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients
    Briac Lefebvre
    Maeva Kyheng
    Jessica Giordano
    Nicolas Lamblin
    Pascal de Groote
    Marie Fertin
    Marie Delobelle
    Thierry Perez
    Jean-Baptiste Faivre
    Jacques Remy
    Alain Duhamel
    Martine Remy-Jardin
    European Radiology, 2022, 32 : 4574 - 4586
  • [44] Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients
    Lefebvre, Briac
    Kyheng, Maeva
    Giordano, Jessica
    Lamblin, Nicolas
    de Groote, Pascal
    Fertin, Marie
    Delobelle, Marie
    Perez, Thierry
    Faivre, Jean-Baptiste
    Remy, Jacques
    Duhamel, Alain
    Remy-Jardin, Martine
    EUROPEAN RADIOLOGY, 2022, 32 (07) : 4574 - 4586
  • [45] Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside
    Mazzola, Matteo
    Madonna, Rosalinda
    Badagliacca, Roberto
    De Caterina, Raffaele
    VASCULAR PHARMACOLOGY, 2022, 145
  • [46] Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension
    Connolly, Michelle J.
    Abdullah, Sharif
    Ridout, Deborah A.
    Schreiber, Benjamin E.
    Haddock, Jamanda A.
    Coghlan, J. Gerry
    RHEUMATOLOGY, 2017, 56 (12) : 2197 - 2203
  • [47] Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno-occlusive disease
    Nakayama, Hiroki
    Ishida, Masayuki
    Nakaoka, Hiroshi
    Nishimura, Yuki
    Imai, Ryu-ichirou
    Sugane, Hiroki
    Hosoda, Hayato
    Nakaoka, Yoko
    Nishida, Koji
    Seki, Shu-ichi
    Kubokawa, Sho-ichi
    Kawai, Kazuya
    Hamashige, Naohisa
    Doi, Yoshinori
    RESPIROLOGY CASE REPORTS, 2023, 11 (07):
  • [48] Safety and Efficacy of Epoprostenol Therapy in Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis
    Ogawa, Aiko
    Miyaji, Katsumasa
    Yamadori, Ichiro
    Shinno, Yoko
    Miura, Aya
    Kusano, Kengo F.
    Ito, Hiroshi
    Date, Hiroshi
    Matsubara, Hiromi
    CIRCULATION JOURNAL, 2012, 76 (07) : 1729 - 1736
  • [49] Pulmonary hypertension: evolution of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Anderson, Ryan J.
    Malhotra, Atul
    Kim, Nick H.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S562 - S565
  • [50] Kynurenine Causes Pulmonary Arterial Relaxation In Pulmonary Hypertension
    Nagy, B. M.
    Nagaraj, C.
    Mangge, H.
    Meinitzer, A.
    Leithner, K.
    Kwapiszewska, G.
    Kovacs, G.
    Foris, V.
    Olschewski, A.
    Olschewski, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193